| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $697.0K | $82.0K | $27.0K |
| YoY Revenue Growth % | +750.0% | +203.7% | — |
| Gross Profit | $425.0K | $50.0K | — |
| Gross Margin % | 61.0% | 61.0% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$12.8M | -$10.5M | -$10.0M |
| Operating Margin % | -80.0% | -80.0% | -80.0% |
| Net Income (GAAP) | -$10.5M | -$10.3M | -$8.5M |
| EBITDA (Normalized) | -$12.7M | -$10.4M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | -$7.7M | -$8.1M | -$8.0M |
| Capital Expenditures (CapEx) | $123.0K | $75.0K | — |
| Free Cash Flow (FCF) | -$7.9M | -$8.2M | -$8.0M |
| FCF Margin % | -80.0% | -80.0% | -80.0% |
| Return on Invested Capital (ROIC %) | -45.0% | -45.0% | — |
| Cash & Short-Term Equivalents | $374.0K | $7.1M | — |
| Total Debt (Short + Long Term) | — | — | — |
| Total Stockholders' Equity | -$3.9M | $6.6M | — |